Correlation Between Moberg Pharma and BioInvent International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moberg Pharma and BioInvent International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moberg Pharma and BioInvent International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moberg Pharma AB and BioInvent International AB, you can compare the effects of market volatilities on Moberg Pharma and BioInvent International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moberg Pharma with a short position of BioInvent International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moberg Pharma and BioInvent International.

Diversification Opportunities for Moberg Pharma and BioInvent International

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Moberg and BioInvent is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Moberg Pharma AB and BioInvent International AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioInvent International and Moberg Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moberg Pharma AB are associated (or correlated) with BioInvent International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioInvent International has no effect on the direction of Moberg Pharma i.e., Moberg Pharma and BioInvent International go up and down completely randomly.

Pair Corralation between Moberg Pharma and BioInvent International

Assuming the 90 days trading horizon Moberg Pharma AB is expected to generate 2.01 times more return on investment than BioInvent International. However, Moberg Pharma is 2.01 times more volatile than BioInvent International AB. It trades about 0.09 of its potential returns per unit of risk. BioInvent International AB is currently generating about 0.13 per unit of risk. If you would invest  775.00  in Moberg Pharma AB on August 25, 2024 and sell it today you would earn a total of  1,051  from holding Moberg Pharma AB or generate 135.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Moberg Pharma AB  vs.  BioInvent International AB

 Performance 
       Timeline  
Moberg Pharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moberg Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
BioInvent International 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BioInvent International AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, BioInvent International unveiled solid returns over the last few months and may actually be approaching a breakup point.

Moberg Pharma and BioInvent International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moberg Pharma and BioInvent International

The main advantage of trading using opposite Moberg Pharma and BioInvent International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moberg Pharma position performs unexpectedly, BioInvent International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioInvent International will offset losses from the drop in BioInvent International's long position.
The idea behind Moberg Pharma AB and BioInvent International AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments